Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
B. Bosse
Observed name:
B Bosse
Institutions:
Klinikum St. Georg,
Mundipharma (Germany)
Observed institutions:
University of Rome Tor Vergata,
Klinikum St. Georg,
Policlinico Tor Vergata,
BG University Hospital Bergmannsheil Bochum,
Mundipharma (Germany),
BG Kliniken,
Mundipharma (Germany)
show all 7
OpenAlex ID:
A5109857936
Fixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer pain
2008
·
K. Simpson
, P. Leyendecker
, et al.
·
Current Medical Research and Opinion
·
192
The Bowel Function Index for Evaluating Constipation in Pain Patients: Definition of a Reference Range for a Non-Constipated Population of Pain Patients
2011
·
MA Ueberall
, S Müller-Lissner
, et al.
·
Journal of International Medical Research
·
110
PDF
An Innovative Topical Drug Formulation for Wound Healing and Infection Treatment: In vitro and in vivo Investigations of a Povidone-Iodine Liposome Hydrogel
2000
·
Karen Reimer
, P.M. Vogt
, et al.
·
Dermatology
·
94
PVP-iodine in hydrosomes and hydrogel—A novel concept in wound therapy leads to enhanced epithelialization and reduced loss of skin grafts
2006
·
P.M. Vogt
, Karen Reimer
, et al.
·
Burns
·
73
Toxicity and/or insufficient analgesia by opioid therapy: risk factors and the impact of changing the opioid. A retrospective analysis of 273 patients observed at a single center
2000
·
M. Kloke
, M. Rapp
, et al.
·
Supportive Care in Cancer
·
60
Long‐term evaluation of combined prolonged‐release oxycodone and naloxone in patients with moderate‐to‐severe chronic pain: pooled analysis of extension phases of two Phase III trials
2014
·
M. Blagden
, J. Hafer
, et al.
·
Neurogastroenterology & Motility
·
36
PDF
A phase III randomized controlled study on the efficacy and improved bowel function of prolonged‐release (PR) oxycodone‐naloxone (up to 160/80 mg daily) vs oxycodone PR
2017
·
D. Dupoiron
, A. Stachowiak
, et al.
·
European Journal of Pain
·
34
PDF
Effect of Polyvinylpyrrolidone-Iodine Liposomal Hydrogel on Wound Microcirculation in SKH1-hr Hairless Mice
2006
·
S. Langer
, N.M. Botteck
, et al.
·
European Surgical Research
·
31
A Clinical Study on the Tolerability of a Liposomal Povidone-Iodine Nasal Spray: Implications for Further Development
2006
·
U. Gluck
, U. Martin
, et al.
·
ORL
·
28
Long‐term efficacy and safety of oxycodone‐naloxone prolonged‐release formulation (up to 180/90 mg daily) – results of the open‐label extension phase of a phase III multicenter, multiple‐dose, randomized, controlled study
2017
·
D. Dupoiron
, A. Stachowiak
, et al.
·
European Journal of Pain
·
25
PDF
Lokale Behandlung von Grad-IIa-Verbrennungen: Wirksamkeit und Verträglichkeit eines neuartigen hydrosomalen Wundgels im Vergleich zu Silbersulfadiazin-Creme
2007
·
J. Hauser
, O. Rossbach
, et al.
·
Der Unfallchirurg
·
16
Was bedeutet Schmerzintensität aus Sicht der Patienten? Eine qualitative Studie zur Patientenperspektive auf Schmerzstärke als Konstrukt in der Therapieevaluation und die Interpretierbarkeit der Schmerzstärkemessung
2017
·
K. Neustadt
, S. Deckert
, et al.
·
Der Schmerz
·
10
Wirksamkeit der Behandlung mit Repithel®und Jelonet®im Vergleich zur alleinigen Anwendung von Jelonet®- eine randomisierte klinische Studie an Meshgraft-Transplantationswunden
2006
·
J. Hauser
, O. Rossbach
, et al.
·
Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie
·
10
Repithel®: Removing the Barriers to Wound Healing
2006
·
S. Mueller
, P.M. Vogt
, et al.
·
Dermatology
·
9
Therapie chronischer Schmerzen mit oralem retardiertem Oxycodon: Behandlungsdaten von 4196 Patienten
2005
·
J. Gaertner
, M. Frank
, et al.
·
Der Schmerz
·
6
The Socioeconomic Costs of the Undertreatment of Pain
2014
·
M. Hopp
, B. Bosse
, et al.
·
Value in Health
·
3
726 Long‐term Efficacy and Safety of Oxycodone and Naloxone in a Prolonged Release (pr) Fixed Combination in Patients With Chronic Pain
2009
·
E.A. Lux
, P. Leyendecker
, et al.
·
European Journal of Pain
·
2
No augmentation during opioid treatment in restless legs syndrome – Results from a 1 year long-term trial
2013
·
R. Kohnen
, B. Bosse
, et al.
·
Sleep Medicine
·
1
Oxycodone/naloxone prolonged-release has positive quality of life outcomes in patients with severe RLS —/INS; Results of a 1-year study
2013
·
R. Kohnen
, H. Benes
, et al.
·
Journal of the Neurological Sciences
·
1
Prolonged-release oxycodone/naloxone is effective in treating pain and constipation in elderly patients with neuropathic pain
2013
·
A. Gatti
, M. Lazzari
, et al.
·
European Geriatric Medicine
·
1
Prolonged-release oxycodone/naloxone effectively reduces pain and constipation in elderly patients with chronic non-malignant pain
2013
·
A. Gatti
, M. Lazzari
, et al.
·
European Geriatric Medicine
·
1
Authors' reply to the comment by Patel J, Martin JH and Lucas CJ
2017
·
M. Hopp
, B. Bosse
·
European Journal of Pain
PDF
Sleep in restless legs syndrome improves during opioid treatment – Results from a large 1-year multi-center trial
2013
·
H. Benes
, C. Trenkwalder
, et al.
·
Sleep Medicine
Opioid treatment is effective in patients with severe RLS after failure of previous medications —/INS; Results of a 1-year study
2013
·
C. Trenkwalder
, H. Benes
, et al.
·
Journal of the Neurological Sciences
Liposomal-verkapseltes PVP-Jod in Hydrogel beschleunigt die Epithelisierung und verbessert die Heilungsqualität — Ein neuer Weg in der Wundtherapie / PVP-Iodine Liposome Hydrogel Improves Epithelialization by Combining Moisture and Antisepsis — A New Concept in Wound Therapy
2001
·
P. M. Vogt
, K. Reimer
, et al.
·
Langenbecks Archiv für Chirurgie. Supplement
Show more works
View as search
Works count:
28
Citation count:
743
H-index:
11
I10-index:
13
Year
Topic
Type